Cumberland Pharmaceuticals (CPIX) Finished Goods (2011 - 2012)
Cumberland Pharmaceuticals (CPIX) posted Finished Goods of $4.9 million for Q4 2012, down 1.85% sequentially from $5.0 million in Q4 2011, and down 1.85% YoY from $5.0 million in Q1 2012.
Cumberland Pharmaceuticals (CPIX) Finished Goods (2011 - 2012) Analysis & Trends
Cumberland Pharmaceuticals has reported Finished Goods for 2 years, with the latest figure at $4.9 million in Q4 2012.
- Quarterly Finished Goods fell 1.85% year-over-year to $4.9 million in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $4.9 million (down 1.85% YoY) and the FY2012 annual result came in at $4.9 million, down 1.85% from the prior year.
- Finished Goods declined to $4.9 million in Q4 2012 per CPIX's latest filing, from $5.0 million in the prior quarter.
- Over five years, Finished Goods peaked at $5.0 million in Q4 2011 and troughed at $4.9 million in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 4.91 Mn |
| Dec 31, 2011 | 5.00 Mn |